drug development Archives

Navigating Medical Research & Development Ahead of the Curve

Industry data show that drug discovery and development can take 12-15 years. It is an extremely complex multi-layered process that always seems to have just one more step. Patients and parents in the rare disease community just want to get the treatments they desperately need as quickly as possible. If you are one of those…

Donald Kirsch: Getting to Know a Drug Hunter

We’ve all been there. You are at a party and someone asks, “So, what do you do?” Dr. Kirsch always found it hard to explain his career as a discovery scientist. He decided to write a book about it. The Drug Hunters: An Improbable Quest to Discover New Medicines is a colorful, fact-filled narrative history of the search for new medicines…

Remember Why We Are Doing All This

Meet Kyle Bryant On our next episode of Improbable Developments we welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA…

Coming Soon: Improbable Developments Podcast

The science of drug discovery and development creates a rich landscape for all sorts of stories to unfold.

Each month we are going to talk to someone who was in the trenches of R&D and let them tell their story. We’ll be talking about medicines you may know and some that never saw the light of day.

UPDATE: Online Course Library Grows

Salem Oaks’ portfolio of online courses is growing rapidly. Since last month, we launched two new modules in the R&D decision-making series, bringing the total to four. Check them out and see where we are going next!

Final Installment of Open Water Sets Sail

The fourth module in our series on Decision Making in Pharmaceutical Research and Development. focuses on the decisions required for Phase 1 Clinical Studies. The stakes are higher as people participate in the studies. These first studies establish a beachhead that will allow the team to learn more and more about the compound. It gets pretty exciting!

Bringing Hope to Patients as Partners

At Patients as Partners, our panel spoke about HOPE and asked the audience to think about a few questions.
–What is the power of hope?
–How much is hope worth?
–How much value do you create each time you give or receive hope?

Helping Patients Influence R&D

[social_warfare buttons=”Facebook, Twitter, LinkedIn”]Healthcare is rapidly changing. Patients, their families, and their advocates are playing a bigger role in decision-making about their care. In addition, the biopharmaceutical industry is realizing that patients can make a valuable contribution to the entire R&D process. They are looking for patients (and others) who can influence the direction of…

Making a Change

The acorn has sprouted Salem Oaks has done a lot in the last year or so. When this company began it was just an idea. Over the last year, not only has the company grown, but projects are now under way and in action. We are actively gaining an understanding of the needs and…

We Don’t Have 5 years!!

The moment was awkward. We had invited in a handful of patients who had the disease we were working to treat to our annual Development Team all-hands meeting. We wanted to learn from them and to be motivated by them. They poured their hearts out to us. They told us about their lives since the…